Serum MicroRNA Signatures in Migraineurs During Attacks and in Pain-Free Periods

Molecular Neurobiology

Volumn 53, Issue 3, 2016, Pages 1494-1500

  Andersen, Hjalte H ^a   Duroux, Meg ^a   Gazerani, Parisa ^a  

^a AALBORG UNIVERSITY   (Denmark)

Author keywords

Biomarker; Headache; MicroRNA; Migraine; Serum

Indexed keywords

MICRORNA; MICRORNA 26B 3P; MICRORNA 29C 5P; MICRORNA 34A; MICRORNA 34A 5P; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID RECEPTOR; BIOLOGICAL MARKER; MIRN29 MICRORNA, HUMAN; MIRN34 MICRORNA, HUMAN; MIRN382 MICRORNA, HUMAN;

ADULT; AGE; AGED; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; GENDER; GENE EXPRESSION; HUMAN; MALE; MIGRAINE; PATHOPHYSIOLOGY; RNA ANALYSIS; UPREGULATION; ADOLESCENT; BIOLOGICAL MODEL; BLOOD; CASE CONTROL STUDY; COMPUTER SIMULATION; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; VALIDATION STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOMARKERS; CASE-CONTROL STUDIES; COMPUTER SIMULATION; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MIGRAINE DISORDERS; MODELS, GENETIC; RECEPTORS, GABA; UP-REGULATION; YOUNG ADULT;

EID: 84961112139     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-015-9106-5     Document Type: Article

References (36)

1. Leonardi M, Steiner TJ, Scher AT, Lipton RB (2005) The global burden of migraine: measuring disability in headache disorders with WHO’s Classification of Functioning, Disability and Health (ICF). J Headache Pain 6:429–440. doi:10.1007/s10194-005-0252-4
2. Pietrobon D, Moskowitz MA (2013) Pathophysiology of migraine. Annu Rev Physiol 75:365–391. doi:10.1146/annurev-physiol-030212-183717
3. Villalón CM, Olesen J (2009) The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs. Pharmacol Ther 124:309–323. doi:10.1016/j.pharmthera.2009.09.003
4. Durham P, Papapetropoulos S (2013) Biomarkers associated with migraine and their potential role in migraine management. Headache 53:1262–1277. doi:10.1111/head.12174
5. Vickers KC, Rye K-A, Tabet F (2014) microRNAs in the onset and development of cardiovascular disease. Clin Sci (Lond) 126:183–194. doi:10.1042/CS20130203
6. Møller HG, Rasmussen AP, Andersen HH et al (2013) A systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasion. Mol Neurobiol 47:131–144. doi:10.1007/s12035-012-8349-7
7. Winter J, Jung S, Keller S et al (2009) Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 11:228–234. doi:10.1038/ncb0309-228
8. Andersen HH, Duroux M, Gazerani P (2014) MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditions. Neurobiol Dis 71:159–168. doi:10.1016/j.nbd.2014.08.003
9. Bai G, Ambalavanar R, Wei D, Dessem D (2007) Downregulation of selective microRNAs in trigeminal ganglion neurons following inflammatory muscle pain. Mol Pain 3:15. doi:10.1186/1744-8069-3-15
10. Bali KK, Kuner R (2014) Noncoding RNAs: key molecules in understanding and treating pain. Trends Mol Med 1–12. doi: 10.1016/j.molmed.2014.05.006
11. Orlova IA, Alexander GM, Qureshi RA et al (2011) MicroRNA modulation in complex regional pain syndrome. J Transl Med 9:195. doi:10.1186/1479-5876-9-195
12. Chattopadhyay M, Zhou Z, Hao S et al (2012) Reduction of voltage gated sodium channel protein in DRG by vector mediated miRNA reduces pain in rats with painful diabetic neuropathy. Mol Pain 8:17. doi:10.1186/1744-8069-8-17
13. Bjersing JL, Lundborg C, Bokarewa MI, Mannerkorpi K (2013) Profile of cerebrospinal microRNAs in fibromyalgia. PLoS One 8:e78762. doi:10.1371/journal.pone.0078762
14. Bjersing JL, Bokarewa MI, Mannerkorpi K (2014) Profile of circulating microRNAs in fibromyalgia and their relation to symptom severity: an exploratory study. Rheumatol Int. doi:10.1007/s00296-014-3139-3
15. Beyer C, Zampetaki A, Lin N-Y et al (2014) Signature of circulating microRNAs in osteoarthritis. Ann Rheum Dis. doi:10.1136/annrheumdis-2013-204698
16. Park C-K, Xu Z-Z, Berta T et al (2014) Extracellular microRNAs activate nociceptor neurons to elicit pain via TLR7 and TRPA1. Neuron 82:47–54. doi:10.1016/j.neuron.2014.02.011
17. Opal S, Depalo V (2000) Anti-inflammatory cytokines. Chest J 117:1162–1172
18. Goadsby PJ, Edvinsson L, Ekman R (1990) Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 28:183–187. doi:10.1002/ana.410280213
19. Papandreou O, Soldatou A, Tsitsika A et al (2005) Serum S100beta protein in children with acute recurrent headache: a potentially useful marker for migraine. Headache 45:1313–1316. doi:10.1111/j.1526-4610.2005.00263.x
20. Antonova M, Wienecke T, Olesen J, Ashina M (2013) Prostaglandins in migraine: update. Curr Opin Neurol 26:269–275. doi:10.1097/WCO.0b013e328360864b
21. Hamel E (2007) Serotonin and migraine: biology and clinical implications. Cephalalgia 27:1293–1300. doi:10.1111/j.1468-2982.2007.01476.x
22. Vikelis M, Mitsikostas DD (2007) The role of glutamate and its receptors in migraine. CNS Neurol Disord Drug Targets 6:251–257
23. Sarrouilhe D, Dejean C, Mesnil M (2014) Involvement of gap junction channels in the pathophysiology of migraine with aura. Front Physiol 5:78. doi:10.3389/fphys.2014.00078
24. Staszel T, Zapała B, Polus A et al (2011) Role of microRNAs in endothelial cell pathophysiology. Pol Arch Med Wewn 121:361–366
25. Roggli E, Britan A, Gattesco S et al (2010) Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells. Diabetes 59:978–986. doi:10.2337/db09-0881
26. Burgos KL, Javaherian A, Bomprezzi R et al (2013) Identification of extracellular miRNA in human cerebrospinal fluid by next-generation sequencing. RNA 19:712–722. doi:10.1261/rna.036863.112
27. Gao H-M, Li L, Zhang K-L et al (2010) Impact of migraine attacks on the blood-brain barrier. Chin Med J (Engl) 123:2559–2561. doi:10.3760/cma.j.issn. 0366-6999.2010.18.012
28. Capuano A, De Corato A, Lisi L et al (2009) Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology. Mol Pain 5:43. doi:10.1186/1744-8069-5-43
29. Harper AM, MacKenzie ET, McCulloch J, Pickard JD (1977) Migraine and the blood-brain barrier. Lancet 1:1034–1036
30. Link AS, Kuris A, Edvinsson L (2008) Treatment of migraine attacks based on the interaction with the trigemino-cerebrovascular system. J Headache Pain 9:5–12. doi:10.1007/s10194-008-0011-4
31. Edvinsson L, Tfelt-Hansen P (2008) The blood-brain barrier in migraine treatment. Cephalalgia 28:1245–1258. doi:10.1111/j.1468-2982.2008.01675.x
32. Olesen J, Tfelt-Hansen P, Welc MA, et al. (2005) The headaches (3rd edition), Jürgen Sandkühler, Chapter 11, Inhibition and facilitation of nociception.
33. Welch KM, Chabi E, Bartosh K et al (1975) Cerebrospinal fluid gamma aminobutyric acid levels in migraine. Br Med J 3:516–517
34. Marukawa H, Shimomura T, Takahashi K (1996) Salivary substance P, 5-hydroxytryptamine, and gamma-aminobutyric acid levels in migraine and tension-type headache. Headache 36:100–104
35. Hering R, Kuritzky A (1992) Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo. Cephalalgia 12:81–84
36. Linde M, Mulleners WM, Chronicle EP, McCrory DC (2013) Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev 6, CD010609. doi:10.1002/14651858.CD010609